Pharmacist Suspended for Unsafe Remote Prescribing of High-Risk Medicines
Date of Decision: August 28, 2025
Registrant's Role: Pharmacist
Allegations:
- Prescribed over 3,000 high-risk prescriptions through online pharmacies without proper clinical assessments.
- Relied solely on online questionnaires without face-to-face or virtual consultations.
- Failed to access GP or specialist records, compromising patient safety.
- Issued prescriptions for controlled drugs (e.g., opioids, z-drugs) inappropriately and without due consideration of dependence or misuse.
- Approved repeat prescriptions for patients with signs of drug-seeking behaviour.
- Failed to refer patients to their GPs or implement safety netting.
- Demonstrated a transactional approach to prescribing rather than one based on clinical need or UK prescribing guidance.
Outcome: Four-month suspension with a review; immediate interim suspension ordered.
GPhC Standards Breached:
- Standard 1 – Person-centred care: Failed to put the care of individuals first by not conducting appropriate assessments.
- Standard 2 – Partnership working: Did not collaborate with GPs or other professionals.
- Standard 4 – Professional judgement: Exercised poor judgment in issuing high-risk medications based solely on questionnaires.
- Standard 6 – Communication: Did not engage in any form of meaningful patient communication or follow-up.
- Standard 7 – Confidentiality and privacy: Failed to properly safeguard patient data and history by neglecting to access GP records.
- Standard 8 – Speaking up about concerns: Did not challenge unsafe prescribing models or raise concerns.
- Standard 9 – Leadership: Did not act as a responsible professional despite having the autonomy to make prescribing decisions.
Case Summary
Allegations
This case concerned serious concerns about a pharmacist’s practice in online prescribing roles at two remote pharmacies: Instant E-Care Ltd and UK Meds Online Ltd. Between May 2019 and January 2020, the registrant issued a combined total of over 4,300 prescriptions, including high-risk medicines such as opioids (codeine, dihydrocodeine), z-drugs (zopiclone, zolpidem), modafinil, antidepressants (sertraline, citalopram), and other medications requiring ongoing monitoring.
Allegations centred on the registrant’s over-reliance on online questionnaires, lack of any virtual or in-person consultations, failure to verify medical histories, and failure to contact patients’ GPs. The prescribing was done in a transactional manner, often in the absence of any safety netting or professional judgment grounded in established clinical guidance.
Continue Reading the Full Case
This case was published more than two weeks ago. A premium subscription is required to read the complete case summary.
- Full allegations considered by the GPhC/PSNI
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
The original determination document is available to registered users.